PRISM (reactor)
PRISM (Power Reactor Innovative Small Module) is an advanced nuclear reactor design developed by General Electric Hitachi Nuclear Energy (GEH). It is a type of integral fast reactor (IFR), which is a class of fast neutron reactor designed to close the nuclear fuel cycle, offering improvements in nuclear waste management and resource utilization. The PRISM design is based on the Experimental Breeder Reactor II (EBR-II) that was operated by the Argonne National Laboratory in the United States from 1964 to 1994.
Design and Features[edit | edit source]
The PRISM reactor is designed to use a sodium coolant, which allows for operation at atmospheric pressure and at higher temperatures than traditional water-cooled reactors. This design choice contributes to the reactor's high level of safety and efficiency. The reactor core is compact and integrates the primary system components, including the reactor vessel, steam generators, and pumps, into a single module. This integral design approach simplifies construction, maintenance, and operation.
One of the key features of the PRISM reactor is its ability to burn a variety of nuclear fuels, including depleted uranium, spent nuclear fuel from other reactors, and plutonium, thus reducing the amount of long-lived radioactive waste. The reactor is capable of generating approximately 311 megawatts of electricity (MWe), making it suitable for small to medium-sized power generation applications.
Safety[edit | edit source]
The PRISM reactor incorporates several passive safety features that rely on natural physical principles, such as gravity and natural convection, to ensure safety in the event of an operational anomaly or accident. These features include a passive decay heat removal system and the use of metallic fuel, which has a higher thermal conductivity than traditional oxide fuels, enhancing the reactor's ability to manage and dissipate heat.
Development and Prospects[edit | edit source]
The development of the PRISM reactor has been influenced by research and operational experience from the EBR-II project. Although the PRISM design has not yet been constructed or operated, it represents a significant advancement in nuclear reactor technology, with the potential to address some of the most pressing issues facing the nuclear power industry, including waste management, fuel supply, and safety.
As of the last update, efforts to commercialize the PRISM reactor are ongoing, with GEH actively seeking opportunities for demonstration projects. The successful deployment of PRISM reactors could play a crucial role in the expansion of nuclear power as a sustainable and low-carbon energy source in the future.
See Also[edit | edit source]
PRISM (reactor) Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD